A substantial proportion of patients admitted to hospitals in Italy experienced acute kidney injury (AKI), which was associated with worsened in-hospital mortality outcomes, longer hospital stays, and ...

Empagliflozin stabilizes kidney function and reduces heart failure risk post-myocardial infarction, with eGFR remaining stable over 24 months. The EMPACT-MI trial confirmed empagliflozin's safety when ...

Serious damage to short-term kidney function—known as acute kidney injury, or AKI—can be fatal and also increase the risk of irreversible chronic kidney disease. It can be triggered by stressors ...

Weaning patients with acute kidney injury (AKI) from dialysis while they are still hospitalized may save them from remaining on the treatment for the rest of their lives, according to a new study led ...

Proton pump inhibitors (PPIs) do not appear to worsen kidney function compared with the histamine 2 receptor blocker ranitidine based on two measures, a large cohort study from Spain finds. In fact, ...

Pediatric COVID-19 infection was tied to a higher risk of adverse postacute kidney outcomes, especially among those with preexisting chronic kidney disease or acute kidney injury. Retrospective data ...

Platinum-associated adverse events were more likely in patients with impaired kidney function assessed by serum creatinine and cystatin C -- warranting judicious adjustment of platinum chemotherapy ...

Our kidneys, vital for filtering waste and maintaining fluid balance, often go unnoticed until problems arise, particularly as we age. Like many bodily functions, kidney performance can naturally ...